{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:27:35Z","timestamp":1759580855616},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,20]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Pre-B cell acute lymphoblastic leukaemia (cALL) commonly occurs in young patients and although successful conventional therapies are available (such as cytotoxic drugs and bone marrow transplantation) for a proportion of patients (approximately 30%) these are ultimately unsuccessful. Recurrence of disease is a result of the failure of the immune system to recognize these abnormal cells and down-regulation of crucial molecules required for cognate CD4+ T cell recognition has been postulated as a means of immune escape. In this study we show that an embryonic kidney cell line (293 cells) transfected with CD154 (40\u2003L.1) are capable of not only maintaining the viability of primary ALL cells in culture but can also up-regulate the expression of a number of crucial molecules involved in antigen recognition. We show that 40\u2003L.1 cell stimulation of primary ALL cell cultures can not only enhance the allogeneic and autologous MLR response to such cells but will also induce CTL effectors which are capable of lysing wild-type autologous ALL cells. It is therefore conceivable that such an approach could be used to generate an active anti-tumour response in patients, following conventional therapy, reducing the incidence of recurrence.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2001.01562.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:27:49Z","timestamp":1047378469000},"page":"359-368","source":"Crossref","is-referenced-by-count":5,"title":["Enhancement of cALL immunogenicity by co-culture with a CD154 expressing 293 cell line"],"prefix":"10.1093","volume":"124","author":[{"given":"A J","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Leicester, Leicester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Haworth","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, Leicester Royal Infirmary Trust, Leicester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"Department of Haematology, Leicester Royal Infirmary Trust, Leicester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Immunology, Leicester Royal Infirmary Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Leicester, Leicester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R F L","family":"James","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Leicester, Leicester"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"2022011305532494000_b1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.169.3950.1042","article-title":"A theory of self-nonself discrimination","volume":"169","author":"Bretscher","year":"1970","journal-title":"Science"},{"key":"2022011305532494000_b2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1101\/SQB.1989.054.01.072","article-title":"T-cell clonal anergy","volume":"54","author":"Schwartz","year":"1989","journal-title":"Cold Spring Harbour Symp Quant Biol"},{"key":"2022011305532494000_b3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation","volume":"173","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"2022011305532494000_b4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.7694363","article-title":"Cloning of B7.2, a CTLA-4 counter-receptor that costimulates human T cell proliferation","volume":"262","author":"Freeman","year":"1993","journal-title":"Science"},{"key":"2022011305532494000_b5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.2113314","article-title":"A cell culture model for T lymphocyte clonal anergy","volume":"248","author":"Schwartz","year":"1990","journal-title":"Science"},{"key":"2022011305532494000_b6","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","article-title":"Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumour immunogenicity","volume":"92","author":"Schultze","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011305532494000_b7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0952-7915(94)90075-2","article-title":"Tumour immunotherapy: the tumour cell as antigen-presenting cell","volume":"6","author":"Ostrand-Rosenberg","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"2022011305532494000_b8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1126\/science.7678351","article-title":"Tumour rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells","volume":"259","author":"Townsend","year":"1993","journal-title":"Science"},{"key":"2022011305532494000_b9","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1073\/pnas.90.12.5687","article-title":"Constitutive expression of B7 restores immunogenicity of tumour cells expressing truncated forms of major histocompatibility complex class II molecules","volume":"90","author":"Baskar","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011305532494000_b10","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.4049\/jimmunol.154.6.2794","article-title":"Antitumour immunity elicited by tumour cells transfected by B7.2, a second ligand for CD28\/CTLA-4 costimulatory molecules","volume":"154","author":"Yang","year":"1995","journal-title":"J Immunol"},{"key":"2022011305532494000_b11","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/eji.1830221016","article-title":"Activated human T cells express a ligand for the human B-cell associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes","volume":"22","author":"Lane","year":"1992","journal-title":"Eur J Immunol"},{"key":"2022011305532494000_b12","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1073\/pnas.89.14.6550","article-title":"A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells","volume":"89","author":"Noelle","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011305532494000_b13","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.4049\/jimmunol.150.9.3671","article-title":"Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines","volume":"150","author":"Armitage","year":"1993","journal-title":"J Immunol"},{"key":"2022011305532494000_b14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","article-title":"Pre-B acute lymphoblastic leukaemia cells may induce T cell anergy to alloantigen","volume":"88","author":"Cardoso","year":"1996","journal-title":"Blood"},{"key":"2022011305532494000_b15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0167-5699(90)90018-5","article-title":"The costimulatory function of antigen-presenting cells","volume":"11","author":"Weaver","year":"1990","journal-title":"Immunol Today"},{"key":"2022011305532494000_b16","first-page":"123","article-title":"Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule restricted T lymphocytes","volume":"52","author":"Yewdell","year":"1992","journal-title":"Adv Immunol"},{"key":"2022011305532494000_b17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00771.x","article-title":"Antigen processing for presentation to T lymphocytes: functional mechanisms and implications for the T cell repertoire","volume":"106","author":"Berzofsky","year":"1988","journal-title":"Immunol Rev"},{"key":"2022011305532494000_b18","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V84.10.3261.3261","article-title":"Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumour immunity","volume":"84","author":"Guinan","year":"1994","journal-title":"Blood"},{"key":"2022011305532494000_b19","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.139.10.3260","article-title":"B7, a B-cell-restricted antigen that identifies preactivated B cells","volume":"139","author":"Freedman","year":"1987","journal-title":"J Immunol"},{"key":"2022011305532494000_b20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0167-5699(94)90080-9","article-title":"The B7 and CD28 receptor families","volume":"15","author":"June","year":"1994","journal-title":"Immunol Today"},{"key":"2022011305532494000_b21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.iy.11.040193.001203","article-title":"The role of the CD28 receptor during T cell responses to antigen","volume":"11","author":"Linsley","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"2022011305532494000_b22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0092-8674(05)80059-5","article-title":"Costimulation of antitumour immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4","volume":"71","author":"Chen","year":"1992","journal-title":"Cell"},{"key":"2022011305532494000_b23","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.V85.9.2507.bloodjournal8592507","article-title":"Role of B7.1 in mediating an immune response to myeloid leukaemia cells","volume":"85","author":"Matulonis","year":"1995","journal-title":"Blood"},{"key":"2022011305532494000_b24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.181.2.619","article-title":"Major histocompatibility complex class II+ B7\u20131+ tumour cells are potent vaccines for stimulating tumour rejection in tumour-bearing mice","volume":"181","author":"Baskar","year":"1995","journal-title":"J Exp Med"},{"key":"2022011305532494000_b25","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1182\/blood.V87.7.2938.bloodjournal8772938","article-title":"Irradiated B7\u20131 transduced primary acute myelogenous leukaemia (AML) cells can be used as therapeutic vaccines in murine AML","volume":"87","author":"Dunussi-Joannopoulos","year":"1996","journal-title":"Blood"},{"key":"2022011305532494000_b26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood.V90.2.549","article-title":"Ex vivo generation of human anti-pre-B leukaemia-specific autologous cytolytic T cells","volume":"90","author":"Cardoso","year":"1997","journal-title":"Blood"},{"key":"2022011305532494000_b27","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V94.10.3531.422k14_3531_3540","article-title":"Adoptive T-cell therapy for B-cell acute lymphoblastic leukaemia: preclinical studies","volume":"94","author":"Cardoso","year":"1999","journal-title":"Blood"},{"key":"2022011305532494000_b28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0092-8674(05)80055-8","article-title":"Costimulation of T lymphocytes. The role of CD28, CTLA-4, and B7\/BB1 in interleukin-2 production and immunotherapy","volume":"71","author":"Schwartz","year":"1992","journal-title":"Cell"},{"key":"2022011305532494000_b29","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1073\/pnas.85.9.3095","article-title":"Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms","volume":"85","author":"Boyd","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011305532494000_b30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/eji.1830180107","article-title":"The function of human intercellular adhesion molecule 1 (ICAM-1) in the generation of an immune response","volume":"18","author":"Dougherty","year":"1988","journal-title":"Eur J Immunol"},{"key":"2022011305532494000_b31","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1084\/jem.167.6.1811","article-title":"Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein\u2013Barr virus-positive Burkitt's lymphoma underlies tumour cell escape from virus-specific T cell surveillance","volume":"167","author":"Gregory","year":"1988","journal-title":"J Exp Med"},{"key":"2022011305532494000_b32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-2478(93)90158-X","article-title":"Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukaemia","volume":"39","author":"Archimbaud","year":"1994","journal-title":"Immunol Lett"},{"key":"2022011305532494000_b33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2141.1997.d01-2019.x","article-title":"Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome","volume":"96","author":"Mielcarek","year":"1997","journal-title":"Br J Haematol"},{"key":"2022011305532494000_b34","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V93.6.1992.406k23_1992_2002","article-title":"CD40-activated B-cell chronic lymphocytic leukaemia cells for tumour immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells","volume":"93","author":"Buhmann","year":"1999","journal-title":"Blood"},{"key":"2022011305532494000_b35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.7973657","article-title":"Prevention of T cell anergy by signalling through the \u03b3 chain of the IL-2 receptor","volume":"266","author":"Boussiotis","year":"1994","journal-title":"Science"},{"key":"2022011305532494000_b36","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1084\/jem.180.5.1665","article-title":"CD2 is involved in maintenance and reversal of human alloantigen specific clonal anergy","volume":"180","author":"Boussiotis","year":"1994","journal-title":"J Exp Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01562.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01562.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/124\/3\/359\/42162591\/j.1365-2249.2001.01562.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/124\/3\/359\/42162591\/j.1365-2249.2001.01562.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T15:12:30Z","timestamp":1682089950000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/124\/3\/359\/6461417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,12,20]]},"published-print":{"date-parts":[[2001,12,20]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01562.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,6]]},"published":{"date-parts":[[2001,6]]}}}